COVID-19 in a patient with long-term use of glucocorticoids A study of a familial cluster

COVID-19 in a patient with long-term use of glucocorticoids : A study of a familial cluster

Copyright © 2020 Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 214(2020) vom: 15. Mai, Seite 108413
1. Verfasser: Han, Yuanyuan (VerfasserIn)
Weitere Verfasser: Jiang, Mao, Xia, Da, He, Lichao, Lv, Xin, Liao, Xiaohua, Meng, Jie
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2020
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Case Reports Journal Article Research Support, Non-U.S. Gov't Atypical infection COVID-19 Familial cluster Immunocompromised Incubation period Shedding duration Glucocorticoids
Beschreibung
Zusammenfassung:Copyright © 2020 Elsevier Inc. All rights reserved.
Clusters of patients with novel coronavirus disease 2019 (COVID-19) have been successively reported globally. Studies show clear person-to-person transmission. The average incubation period is 2-14 days, and mostly 3-7 days. However, in some patients, this period may be longer. Here, we report a familial cluster of COVID-19 where a 47-year-old woman with long-term use of glucocorticoids did not develop any symptoms within the 14-day quarantine period but was confirmed with COVID-19 by tested positive of antibody on day 40 after she left Wuhan. Almost at the same time, her father and sister were diagnosed with COVID-19. The results suggest that the long-term use of glucocorticoids might cause atypical infections, a long incubation period, and extra transmission of COVID-19
Beschreibung:Date Completed 05.05.2020
Date Revised 18.12.2020
published: Print-Electronic
Citation Status MEDLINE
ISSN:1521-7035
DOI:10.1016/j.clim.2020.108413